Novel drug combination nanoparticles exhibit enhanced plasma exposure and dose-responsive effects on eliminating breast cancer lung metastasis.
Early diagnosis along with new drugs targeted to cancer receptors and immunocheckpoints have improved breast cancer survival. However, full remission remains elusive for metastatic breast cancer due to dose-limiting toxicities of heavily used, highly potent drug combinations such as gemcitabine and...
Saved in:
Main Authors: | Qingxin Mu, Jesse Yu, James I Griffin, Yan Wu, Linxi Zhu, Lisa A McConnachie, Rodney J Y Ho |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2020
|
Subjects: | |
Online Access: | https://doaj.org/article/cb89d7d76ccd4535a410f364e5bbf9bc |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Perifosine, a Bioavailable Alkylphospholipid Akt Inhibitor, Exhibits Antitumor Activity in Murine Models of Cancer Brain Metastasis Through Favorable Tumor Exposure
by: Keisuke Taniguchi, et al.
Published: (2021) -
Optimisation and Prediction of the Coagulant Dose for the Elimination of Organic Micropollutants Based on Turbidity
by: Hichem Tahraoui, et al.
Published: (2021) -
Plasma redox imbalance caused by albumin oxidation promotes lung-predominant NETosis and pulmonary cancer metastasis
by: Minoru Inoue, et al.
Published: (2018) -
Proton beam radiotherapy in the management of uveal melanoma: Clinical experience in Scotland
by: Samir Aziz, et al.
Published: (2008) -
Multiomics Landscape Uncovers the Molecular Mechanism of the Malignant Evolution of Lung Adenocarcinoma Cells to Chronic Low Dose Cadmium Exposure
by: Shun-Dong Dai, et al.
Published: (2021)